Analysts are projecting Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) to grow at an accelerated rate over the next five years. Sell-side analysts are looking for the company to grow 12.20% over the next year and 60.00% over the next five years.
EPS measures what each share is worth and also indicates how much money their sharehoders would gain if the company was to pay out all of its profits. Earnings Per Share is computed by dividing the total profit by its total shares. If a company’s profit is $800 million and there are 40 million shares, then the EPS is $20. EPS is a great way to compare and contrast companies from the same industry. When a company shows a steady rising earnings trend, this indicates that the firm will have an advantage over companies with a more volatile earnings trend. Rigel Pharmaceuticals, Inc.’s trailing 12- months EPS is -0.72. Last year, their EPS growth was 43.90% and their EPS growth over the past five years was -22.90%.
Let’s start off by taking a look at how the stock has been performing recently. Over the past twelve months, Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)’s stock was -10.89%. Last week, it was 0.37%, 2.27% over the last quarter, and 4.65% for the past half-year.
Over the past 50 days, Rigel Pharmaceuticals, Inc. stock was -38.58% off of the high and 37.95% removed from the low. Their 52-Week High and Low are noted here. -38.58% (High), 43.09%, (Low).
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)’s performance this year to date is -10.89%. The stock has performed 0.37% over the last seven days, 5.88% over the last thirty, and 2.27% over the last three months. Over the last six months, Rigel Pharmaceuticals, Inc.’s stock has been 4.65% and -17.93% for the year.
FUTURE GROWTH ESTIMATES AND RECOMMENDATIONS
Wall Street analysts are have a consensus analyst recommendation of 1.80 on the stock. This is based on a 1-5 scale where 1 represents a Strong Buy and 5 a Strong Sell. Brokerages covering the name have a $6.20 on the stock.
The advice provided on this website is general advice only. It has been prepared without taking into account your objectives, financial situation or needs. Before acting on this advice you should consider the appropriateness of the advice, having regard to your own objectives, financial situation and needs. Where quoted, past performance is not indicative of future performance.